Overview:

The anti-nCoV S1 Human IgG-IgA-IgM ELISA Kit is an enzyme-linked immunosorbent assay for the pan-specific detection of Human anti-nCoV Spike protein S1 IgG-IgA-IgM in serum or other biological samples. Based on indirect ELISA principles, the anti-nCoV S1 Human IgG-IgA-IgM ELISA employs recombinant nCoV Spike protein RBD coated on a 96-well plate. Controls and samples (with necessary dilution) are pipetted into the wells; the target IgG-IgA-IgM in the controls and samples binds to the immobilized Spike protein. The intensity of color development in the wells is proportional to the amount of target IgG-IgA-IgM bound.

Components:

References:

1. Zhou P, et al: A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020, 579:270-89.

2. Xiao X, et al: The SARS-CoV S glycoprotein. Cell Mol Life Sci. 2004, 61 (19-20): 2428-30.

3. Long Q, et al: Antibody responses to SARS-CoV-2 in patients with COVID-19 Quan-Xin Long. Nature Medicine. 2020, 29 April.

4. Ma H, et al: Serum IgA, IgM, and IgG responses in COVID-19. Cell Mol Immunol. 2020, 17: 773-775.